title: An overview of the China Bioanalytical Forum: interview with Daniel Tang.
abstract: Daniel Tang talks to Sankeetha Nadarajah, Commissioning Editor (Bioanalysis), regarding the China Bioanalysis Forum (CBF), in which Daniel was one of the co-founders and remains as its co-chair. Daniel is currently the CEO of UP Pharma, a biologics focused bioanalytical CRO in China.
authors.affiliation: United-Power PharmaTech, Beijing, China.
authors.forename: Daniel
authors.initials: D
authors.lastname: Tang
mesh_terms: D001688:Biological Products; D001709:Biotechnology / Q000379:methods*; D002681:China; D004345:Drug Industry / Q000639:trends; D033161:Government Regulation; D007391:International Cooperation; D013678:Technology, Pharmaceutical / Q000639:trends
chemical_list: D001688:Biological Products
keywords: CBF; China bioanalysis regulation; GLP